DK3319625T3 - Immunogene præ-procalcitoninpeptider - Google Patents

Immunogene præ-procalcitoninpeptider Download PDF

Info

Publication number
DK3319625T3
DK3319625T3 DK16734656.8T DK16734656T DK3319625T3 DK 3319625 T3 DK3319625 T3 DK 3319625T3 DK 16734656 T DK16734656 T DK 16734656T DK 3319625 T3 DK3319625 T3 DK 3319625T3
Authority
DK
Denmark
Prior art keywords
immunogene
procalcitonin
peptides
procalcitonin peptides
immunogene pre
Prior art date
Application number
DK16734656.8T
Other languages
English (en)
Inventor
Fathia Mami-Chouaib
Aurélie Durgeau
Original Assignee
Roussy Inst Gustave
Inst Nat Sante Rech Med
Univ Paris Sud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussy Inst Gustave, Inst Nat Sante Rech Med, Univ Paris Sud filed Critical Roussy Inst Gustave
Application granted granted Critical
Publication of DK3319625T3 publication Critical patent/DK3319625T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK16734656.8T 2015-07-09 2016-07-04 Immunogene præ-procalcitoninpeptider DK3319625T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15176174.9A EP3115058A1 (fr) 2015-07-09 2015-07-09 Peptides immunogenes de preprocalcitonine
PCT/EP2016/065733 WO2017005702A1 (fr) 2015-07-09 2016-07-04 Peptides immunogenes de preprocalcitonine

Publications (1)

Publication Number Publication Date
DK3319625T3 true DK3319625T3 (da) 2020-03-30

Family

ID=53539598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16734656.8T DK3319625T3 (da) 2015-07-09 2016-07-04 Immunogene præ-procalcitoninpeptider

Country Status (9)

Country Link
US (1) US11179449B2 (da)
EP (2) EP3115058A1 (da)
JP (1) JP6811194B2 (da)
CN (1) CN108025044B (da)
AU (1) AU2016289727B2 (da)
CA (1) CA2990893C (da)
DK (1) DK3319625T3 (da)
ES (1) ES2777535T3 (da)
WO (1) WO2017005702A1 (da)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
AU2001253852A1 (en) * 2000-03-31 2001-10-15 Institut Gustave Roussy Preprocalcitonin as tumor rejection antigen precursor and uses thereof
WO2008021290A2 (en) * 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
EP2006384A1 (en) 2007-06-22 2008-12-24 Institut Gustave Roussy Preprocalcitonin-derived antigen epitopes

Also Published As

Publication number Publication date
EP3319625A1 (fr) 2018-05-16
JP2018520152A (ja) 2018-07-26
EP3115058A1 (fr) 2017-01-11
EP3319625B1 (fr) 2020-01-01
US20180200355A1 (en) 2018-07-19
US11179449B2 (en) 2021-11-23
WO2017005702A1 (fr) 2017-01-12
AU2016289727A1 (en) 2018-02-08
JP6811194B2 (ja) 2021-01-13
CA2990893A1 (fr) 2017-01-12
AU2016289727B2 (en) 2022-03-17
CA2990893C (fr) 2023-11-28
CN108025044B (zh) 2022-03-25
ES2777535T3 (es) 2020-08-05
CN108025044A (zh) 2018-05-11

Similar Documents

Publication Publication Date Title
DK3207053T3 (da) Hidtil ukendte immunogene peptider
DK4089113T3 (da) Polypeptider
DK3723783T3 (da) Mitokondrie-målrettede peptider
GB201520559D0 (en) Peptides
KR20180084876A (ko) 내플라즈마성 부재
GB201515745D0 (en) Proteins
GB201511787D0 (en) Proteins
GB201520536D0 (en) Peptides
GB201520563D0 (en) Peptides
GB201520546D0 (en) Peptides
GB201520545D0 (en) Peptides
GB201520539D0 (en) Peptides
GB201520550D0 (en) Peptides
GB201520562D0 (en) Peptides
GB201520567D0 (en) Peptides
GB201520543D0 (en) Peptides
GB201520544D0 (en) Peptides
GB201520541D0 (en) Peptides
GB201513033D0 (en) Proteins
GB201520557D0 (en) Peptides
GB201520542D0 (en) Peptides
GB201520570D0 (en) Peptides
GB201520568D0 (en) Peptides
GB201520566D0 (en) Peptides
GB201520558D0 (en) Peptides